Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M (marzo de 1998). "Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor". Cell92 (6): 735–45. PMID9529250. doi:10.1016/S0092-8674(00)81402-6.
Chen H, Chédotal A, He Z, Goodman CS, Tessier-Lavigne M (setembro de 1997). "Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III". Neuron19 (3): 547–59. PMID9331348. doi:10.1016/S0896-6273(00)80371-2.
Mamluk R, Gechtman Z, Kutcher ME, Gasiunas N, Gallagher J, Klagsbrun M (xullo de 2002). "Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain". The Journal of Biological Chemistry277 (27): 24818–25. PMID11986311. doi:10.1074/jbc.M200730200.
Fakhari M, Pullirsch D, Abraham D, Paya K, Hofbauer R, Holzfeind P, Hofmann M, Aharinejad S (xaneiro de 2002). "Selective upregulation of vascular endothelial growth factor receptors neuropilin-1 and -2 in human neuroblastoma". Cancer94 (1): 258–63. PMID11815985. doi:10.1002/cncr.10177.
Latil A, Bièche I, Pesche S, Valéri A, Fournier G, Cussenot O, Lidereau R (marzo de 2000). "VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms". International Journal of Cancer89 (2): 167–71. PMID10754495. doi:10.1002/(SICI)1097-0215(20000320)89:2<167::AID-IJC11>3.0.CO;2-9.
Hong TM, Chen YL, Wu YY, Yuan A, Chao YC, Chung YC, Wu MH, Yang SC, Pan SH, Shih JY, Chan WK, Yang PC (agosto de 2007). "Targeting neuropilin 1 as an antitumor strategy in lung cancer". Clinical Cancer Research13 (16): 4759–68. PMID17699853. doi:10.1158/1078-0432.CCR-07-0001.
Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M (marzo de 1998). "Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor". Cell92 (6): 735–45. PMID9529250. doi:10.1016/S0092-8674(00)81402-6.
Chen H, Chédotal A, He Z, Goodman CS, Tessier-Lavigne M (setembro de 1997). "Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III". Neuron19 (3): 547–59. PMID9331348. doi:10.1016/S0896-6273(00)80371-2.
Mamluk R, Gechtman Z, Kutcher ME, Gasiunas N, Gallagher J, Klagsbrun M (xullo de 2002). "Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain". The Journal of Biological Chemistry277 (27): 24818–25. PMID11986311. doi:10.1074/jbc.M200730200.
Fakhari M, Pullirsch D, Abraham D, Paya K, Hofbauer R, Holzfeind P, Hofmann M, Aharinejad S (xaneiro de 2002). "Selective upregulation of vascular endothelial growth factor receptors neuropilin-1 and -2 in human neuroblastoma". Cancer94 (1): 258–63. PMID11815985. doi:10.1002/cncr.10177.
Latil A, Bièche I, Pesche S, Valéri A, Fournier G, Cussenot O, Lidereau R (marzo de 2000). "VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms". International Journal of Cancer89 (2): 167–71. PMID10754495. doi:10.1002/(SICI)1097-0215(20000320)89:2<167::AID-IJC11>3.0.CO;2-9.
Bachelder RE, Crago A, Chung J, Wendt MA, Shaw LM, Robinson G, Mercurio AM (agosto de 2001). "Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells". Cancer Research61 (15): 5736–40. PMID11479209.
Hong TM, Chen YL, Wu YY, Yuan A, Chao YC, Chung YC, Wu MH, Yang SC, Pan SH, Shih JY, Chan WK, Yang PC (agosto de 2007). "Targeting neuropilin 1 as an antitumor strategy in lung cancer". Clinical Cancer Research13 (16): 4759–68. PMID17699853. doi:10.1158/1078-0432.CCR-07-0001.